• Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues – Archives
  • Subscribe
  • Contact
Facebook Twitter Instagram
Trending
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia
Wednesday, October 1
Facebook Twitter Instagram LinkedIn
Biotech Express
  • Home
  • Editorial Board
  • Articles
    • Editorials
    • Guest Articles
  • News
    • Featured
    • Biotech News
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    04/01/20241

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    Recent
    04/01/2024

    Interview: Reach to common man is the heart and soul of India International Science Festival- Dr. Arvind C Ranade Chief Coordinator, IISF- 2023

    22/05/2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    26/07/2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

  • Issues – Archives
  • Subscribe
  • Contact
Biotech Express
You are at:Home»Biotech News»KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam

KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam

0
By Biotech Express on 16/09/2025 Biotech News, Controversial, Featured

In a significant development at King George’s Medical University (KGMU) in Lucknow, Uttar Pradesh, the university’s newly formed purchase committee has accused the Transfusion Medicine Department of major financial irregularities spanning from 2015 to 2025. The allegations primarily target Dr. Tulika Chandra, the former head of the department, involving a multi-crore scam related to inflated testing charges, procurement fraud, misuse of funds, and forgery of signatures. This controversy erupted in early August 2025 and has led to investigations, her temporary removal from the post, and subsequent reinstatement under conditions.

After scam surfaced, there has been a reduction of 17X in all expenses including investigation fees in the Department of Transfusion Medicine.

Serious questions have been raised on the purchases worth crores of rupees during his tenure. It is alleged that the first owner of the vehicles purchased in the name of Dr. Tulika and her son is Shiv Shankar Singh. The shocking thing is that the name of the owner of Yashika Enterprises, a firm that supplies to the Transfusion Medicine Department, is also Shiv Shankar Singh.

The Transfusion Medicine Department at KGMU handles blood bank operations, including tests for HIV, Hepatitis B and C, and syphilis, often funded by the National Health Mission (NHM). The purchase committee, formed in response to initial complaints, conducted an audit that uncovered several discrepancies:

1. Inflated Testing Charges: Under NHM guidelines, tests via Chemiluminescence machines are reimbursed at ₹265 per blood bag. However, the department allegedly charged over ₹500 per test, leading to overpricing. Reports indicate that tests costing as little as ₹5 elsewhere were billed at ₹85 in KGMU, resulting in substantial financial losses to the government. Consumables that are provided free in other institutions like AIIMS were also paid for here, with costs several times higher than comparative rates.

2. Procurement Scam and Unused Supplies: The committee found that crores worth of equipment and materials were procured annually, but much of it remained unused. Several purchase files are under suspicion for irregularities. Notably, no formal purchase committee existed in the department until the forgery issue surfaced, allowing unchecked spending. Suppliers were allegedly favored through suspicious relationships, pointing to potential kickbacks.

3. Forgery of Signatures and Document Tampering: Forensic investigations confirmed fake signatures of faculty members on stock registers and official documents, dating back to April 2024.

Dr. Chandra, as the then-head, is accused of forging these to approve procurements and cover up discrepancies. She was also alleged to have failed to hand over charge to a senior doctor during leave, exacerbating administrative lapses.

These issues came to light after a whistleblower complaint in 2024, leading to a high-level inquiry. The 54th Executive Council meeting on August 27, 2024, demanded a thorough audit of past purchases and removed Dr. Chandra from her position pending investigation.

Timeline of Events

• April 2024: Initial complaint about fake faculty signatures in the Vice-Chancellor’s office.
• July 2024: Forensic report confirms forgery.
• August 2024: Purchase committee formed; audit reveals financial irregularities.
• August 6, 2025: Media reports (e.g., Prabhat Khabar) expose the multi-crore scam, demanding a high-level probe.
• August 18-19, 2025: Navbharat Times details the overpricing and forgery, labeling it a “scam” involving Dr. Chandra.
• August 22, 2025: KGMU Executive Council, chaired by Vice-Chancellor Dr. Sonia Nityanand, approves a disciplinary committee. Dr. Chandra is issued a charge sheet for private practice allegations (separate but concurrent issue) but reinstated as department head after the procurement tampering probe finds “no evidence.” She will face conditions during ongoing investigations.
• Ongoing: Calls for a comprehensive external audit persist from faculty and activists, with the university’s spokesperson stating full compliance with legal processes.

Source: https://navbharattimes.indiatimes.com/metro/lucknow/crime/up-kgmu-purchase-committee-accuse-transfusion-medicine-department-dr-tulika-chandra-of-scam-latest-update/articleshow/123375100.cms

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?”

Zydus to launch market-specific dosage variants of Semaglutide, MD says

Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia

Leave A Reply Cancel Reply

Current Issue – September 2025
Biotech Express – e-ISSN: 2454-6968

Editorial Board

For Authors – Article Submission and Guidelines

Peer Review Policies

License and Copyright

Advertisement

Recent Posts
  • CDC Boss kicked out in RFK Jr.’s War on Corruption in pharma and healthcare 21/09/2025
  • Prof. Rajeev Varshney FRS, now joins Australian Academy of Science 20/09/2025
  • Dr. Cyrus S. Poonawalla, SII unveiled the newly built School for Hearing Impaired in Pune 19/09/2025
  • AdFalciVax: ICMR’s New Malaria Vaccine: Hope or Premature Hype?” 18/09/2025
  • The Sudden Deaths and COVID Vaccines: A Critical Analysis of the ICMR and AIIMS Studies 17/09/2025
  • KGMU Scandal: Dr. Tulika Chandra Exposed in Crore Rupee Forgery and Scam 16/09/2025
  • Zydus to launch market-specific dosage variants of Semaglutide, MD says 15/09/2025
  • Biocon Biologics Launches Nepexto, Etanercept Biosimilar in Australia 15/09/2025
  • India launched its first National Biofoundry Network 15/09/2025
  • India has 94 Biotech Incubators across 25 states over 13 years 15/09/2025
Archives
Categories
  • Articles
  • Biotech News
  • Controversial
  • Editorials
  • Events
  • Featured
  • Guest Articles
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • News-Industry
  • News-Research
  • Policies
  • SARS- CoV2 & COVID-19 Updates
  • Start-ups
About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Submission Policy and Guidelines

Submission policies

 

 

Follow us on Social Media
  • Facebook
  • Twitter
  • YouTube
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2025 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.